人感染H7N9禽流感病毒B细胞免疫应答
结题报告
批准号:
81830050
项目类别:
重点项目
资助金额:
295.0 万元
负责人:
严景华
学科分类:
炎症、感染与免疫
结题年份:
2023
批准年份:
2018
项目状态:
已结题
项目参与者:
严景华
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
2013年以来,H7N9禽流感疫情多次暴发,其高致死率使得H7N9感染成为一个重要的公共卫生事件。流感病毒HA蛋白是流感病毒主要的免疫源,其抗原优势表位主要在HA的头部区,头部区高度可变性导致病毒很容易逃脱既往感染或疫苗免疫产生的免疫压力。尽管保守的HA的茎部能产生广谱性中和抗体,然而这类抗体在新的病毒感染时并没有起到有效的保护作用。因此阐明H7N9感染过程中B细胞响应机制对流感广谱性疫苗的设计具有重要指导意义。本研究拟利用流式分选结合单细胞测序技术从H7N9感染康复者B细胞中分离天然配对H7N9中和抗体,这些抗体能够真实反映人体B细胞对感染过程的响应;然后用结构生物学的手段鉴定抗原表位;再利用反向遗传技术构建不同表位抗体逃逸病毒株,研究人感染H7N9病毒后不同表位抗体产生的动力学过程,揭示B细胞的免疫应答机制。同时筛选到的中和抗体也为H7N9感染病人,尤其是重症病人提供治疗性候选药物。
英文摘要
Since 2013, a novel H7N9 avian influenza viruses have caused a major outbreak in humans in China. The high mortality of H7N9 infection has become a major public health event. The hemagglutinin (HA) of influenza virus is the major immunogen. Most strain-specific neutralizing antibodies formed in response to influenza vaccination or infection are directed toward highly variable and mutable regions of HA globular head region responsible for viral attachment to host cells. Influenza viruses reinfect previously immune hosts by acquiring escape mutations in the epitopes of neutralizing antibodies. The preexisting broadly neutralizing antibody targeting conserved stem region of HA can't prevent human from mutated viruses, but the mechanism is not clear. To clarify B cell response to H7N9 infection and guide the design of broadly influenza vaccines, H7N9 infected patient blood samples will be collected in this study. The neutralizing antibody level of serum and B cell response will be assessed. H7N9 neutralization antibodies will be isolated from H7N9 infected B cells by single cell sequencing Further, the structure of antigen and antibody complex will be solved. Based on the complex structure, antigenic determinant will be confirmed. Then we will generate a panel of escape virus strains which include key amino acid residue mutation of determinant using reverse genetics. These viruses in which one antigenic site is identical to the parental virus, whereas the other sites are antigenically altered will be used to analyze the dynamic process of neutralization antibodies in H7N9-infected patients and find immunodominant determinant of H7N9 avian influenza virus.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1038/s41392-022-00879-2
发表时间:2022
期刊:Signal Transduction and Targeted Therapy
影响因子:39.3
作者:Duan Xiaomin;Shi Rui;Liu Pulan;Huang Qingrui;Wang Fengze;Chen Xinyu;Feng Hui;Huang Weijin;Xiao Junyu;Yan Jinghua
通讯作者:Yan Jinghua
DOI:doi.org/10.1038/s41467-021-25331-x
发表时间:2021
期刊:Nature Communications
影响因子:16.6
作者:Yanyun Du;Rui Shi;Ying Zhang;Xiaomin Duan;Li Li;Jing Zhang;Fengze Wang;Ruixue Zhang;Hao Shen;Yue Wang;Zheng Wu;Qianwen Peng;Ting Pan;Wanwei Sun;Weijin Huang;Yue Feng;Hui Feng;Junyu Xiao;Wenjie Tan;Youchun Wang;Chenhui Wang;Jinghua Yan
通讯作者:Jinghua Yan
A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
基于六螺旋束融合核心三聚化受体结合域的 SARS-CoV-2 和 H1N1 流感联合疫苗
DOI:10.1016/j.ebiom.2022.104297
发表时间:2022-11
期刊:EBIOMEDICINE
影响因子:11.1
作者:Shi, Rui;Zeng, Jiawei;Xu, Ling;Wang, Fengze;Duan, Xiaomin;Wang, Yue;Wu, Zheng;Yu, Dandan;Huang, Qingrui;Yao, Yong-Gang;Yan, Jinghua
通讯作者:Yan, Jinghua
DOI:10.1080/22221751.2022.2032374
发表时间:2022-12
期刊:Emerging microbes & infections
影响因子:13.2
作者:Wang F;Li L;Dou Y;Shi R;Duan X;Liu H;Zhang J;Liu D;Wu J;He Y;Lan J;Lu B;Feng H;Yan J
通讯作者:Yan J
非洲猪瘟病毒主要蛋白结构与功能研究
  • 批准号:
    31941003
  • 项目类别:
    专项基金项目
  • 资助金额:
    300万元
  • 批准年份:
    2019
  • 负责人:
    严景华
  • 依托单位:
卡波氏肉瘤疱疹病毒(KSHV/ HHV8)膜融合机制研究
Na/K-ATPase beta 1亚基与流感病毒M2蛋白相互作用及功能研究
流感病毒M2蛋白与宿主细胞热休克蛋白Hsp40相互作用及对p58IPK介导的PKR信号途径的调节
国内基金
海外基金